British Journal of Haematology

Acute promyelocytic leukaemia presenting with a myeloid sarcoma of the tongue
pp. 565-565(1)
Authors: Mohamedbhai, S.; Pule, M.; Conn, B.; Hopper, C.; Ramsay, A.; Khwaja, A.

Bortezomib-induced reversible posterior leucoencephalopathy syndrome
pp. 566-566(1)
Authors: Kelly, Kevin; Kalachand, Roshni; Murphy, Philip

Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia
pp. 567-575(9)
Authors: Koike, Kenichi; Matsuda, Kazuyuki

Farnesyltransferase inhibitors and their potential role in therapy for myelodysplastic syndromes and acute myeloid leukaemia
pp. 576-586(11)
Authors: Braun, Thorsten; Fenaux, Pierre

Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients
pp. 587-597(11)
Authors: Prandoni, Paolo; Samama, Michel M.

p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications
pp. 598-606(9)
Authors: Ishitsuka, Kenji; Hideshima, Teru; Neri, Paola; Vallet, Sonia; Shiraishi, Norihiko; Okawa, Yutaka; Shen, Zhenxin; Raje, Noopur; Kiziltepe, Tanyel; Ocio, Enrique M.; Chauhan, Dharminder; Tassone, Pierfrancesco; Munshi, Nikhil; Campbell, Robert M.; Dios, Alfonso De; Shih, Chuan; Starling, James J.; Tamura, Kazuo; Anderson, Kenneth C.

Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia
pp. 607-614(8)
Authors: Palmer, Shanique; Hanson, Curtis A.; Zent, Clive S.; Porrata, Luis F.; LaPlant, Betsy; Geyer, Susan M.; Markovic, Svetomir N.; Call, Timothy G.; Bowen, Deborah A.; Jelinek, Diane F.; Kay, Neil E.; Shanafelt, Tait D.

The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma
pp. 615-621(7)
Authors: Zent, Clive S.; Ding, Wei; Schwager, Susan M.; Reinalda, Megan S.; Hoyer, James D.; Jelinek, Diane F.; Tschumper, Renee C.; Bowen, Deborah A.; Call, Timothy G.; Shanafelt, Tait D.; Kay, Neil E.; Slager, Susan L.

High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia
pp. 622-630(9)
Authors: Forconi, Francesco; Poretti, Giulia; Kwee, Ivo; Sozzi, Elisa; Rossi, Davide; Rancoita, Paola M. V.; Capello, Daniela; Rinaldi, Andrea; Zucca, Emanuele; Raspadori, Donatella; Spina, Valeria; Lauria, Francesco; Gaidano, Gianluca; Bertoni, Francesco

Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients
pp. 631-640(10)
Authors: Hirt, Carsten; Schüler, Frank; Kiefer, Thomas; Schwenke, Cornelia; Haas, Antje; Niederwieser, Dietger; Neser, Sabine; Aßmann, Michael; Srock, Stefanie; Rohrberg, Robert; Dachselt, Klaus; Leithäuser, Malte; Rabkin, Charles S.; Herold, Michael; Dölken, Gottfried

THOC5 spliceosome protein: a target for leukaemogenic tyrosine kinases that affects inositol lipid turnover
pp. 641-650(10)
Authors: Pierce, Andrew; Carney, Louise; Hamza, Hajja G.; Griffiths, John R.; Zhang, Liqun; Whetton, Beth A.; Gonzalez Sanchez, M. Belen; Tamura, Teruko; Sternberg, David; Whetton, Anthony D.

Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse
pp. 651-658(8)
Authors: Jin, Ming; Casper, T. Charles; Cataland, Spero R.; Kennedy, Melanie S.; Lin, Shili; Li, Yu J.; Wu, Haifeng M.

Retraction: Fatty acid synthase is a novel therapeutic target in multiple myeloma
pp. 659-671(13)
Authors: Okawa, Yutaka; Hideshima, Teru; Ikeda, Hiroshi; Raje, Noopur; Vallet, Sonia; Kiziltepe, Tanyel; Yasui, Hiroshi; Enatsu, Sotaro; Pozzi, Samantha; Breitkreutz, Iris; Cirstea, Diana; Santo, Loredana; Richardson, Paul; Anderson, Kenneth C.

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
pp. 672-675(4)
Authors: Lawrie, Charles H.; Gal, Shira; Dunlop, Heather M.; Pushkaran, Beena; Liggins, Amanda P.; Pulford, Karen; Banham, Alison H.; Pezzella, Francesco; Boultwood, Jacqueline; Wainscoat, James S.; Hatton, Christian S. R.; Harris, Adrian L.

Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin family
pp. 676-680(5)
Authors: Evens, Andrew M.; Schumacker, Paul T.; Helenowski, Irene B.; Singh, Amareshwar T. K.; Dokic, Danijela; Keswani, Anjeni; Kordeluk, Elizabeth; Raji, Adekunle; Winter, Jane N.; Jovanovic, Borko D.; Holmgren, Arne; Nelson, Beverly P.; Gordon, Leo I.

Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome
pp. 681-688(8)
Authors: Sato, Tomohiko; Toki, Tsutomu; Kanezaki, Rika; Xu, Gang; Terui, Kiminori; Kanegane, Hirokazu; Miura, Masayoshi; Adachi, Souichi; Migita, Masahiro; Morinaga, Shingo; Nakano, Takahide; Endo, Mikiya; Kojima, Seiji; Kiyoi, Hitoshi; Mano, Hiroyuki; Ito, Etsuro

Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters
pp. 689-695(7)
Authors: Mancuso, Maria Elisa; Mannucci, Pier Mannuccio; Sartori, Angelo; Agliardi, Andrea; Santagostino, Elena

Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison
pp. 696-707(12)
Authors: Karpac, Charity A.; Li, Xiaoning; Terrell, Deirdra R.; Kremer Hovinga, Johanna A.; Lämmle, Bernhard; Vesely, Sara K.; George, James N.

Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains
pp. 708-715(8)
Authors: Chaves, D. G.; Velloso-Rodrigues, C.; Moreau, V.; Nguyen, C.; Villard, S.; Belisário, A. R.; Granier, C.; Santoro, M. M.

Fibrinolytic inhibitor levels and polymorphisms in Behçet disease and their association with thrombosis
pp. 716-719(4)
Authors: Ricart, José M.; Ramón, Luis A.; Vayá, Amparo; España, Francisco; Santaolaria, Maria-Luisa; Todolí, José; Castelló, Remedios; Fontcuberta, Jordi; Estellés, Amparo

Induction of gamma-globin gene transcription by hydroxycarbamide in primary erythroid cell cultures from Lepore patients
pp. 720-727(8)
Authors: Calzolari, Roberta; Pecoraro, Alice; Borruso, Vito; Troia, Antonio; Acuto, Santina; Maggio, Aurelio; Di Marzo, Rosalba

Effect of deferasirox (ICL670) on arterial function in patients with beta-thalassaemia major
pp. 728-733(6)
Authors: Cheung, Y. F.; Chan, Godfrey C. F.; Ha, S. Y.

Early stage chronic lymphocytic leukaemia carrying unmutated IGHV genes is at risk of recurrent infections during watch and wait
pp. 734-736(3)
Authors: Rossi, Davide; De Paoli, Lorenzo; Rossi, Francesca M.; Cerri, Michaela; Deambrogi, Clara; Rasi, Silvia; Zucchetto, Antonella; Capello, Daniela; Gattei, Valter; Gaidano, Gianluca

Marrow osteopontin level as a prognostic factor in acute myeloid leukaemia
pp. 736-739(4)
Authors: Lee, Cheng-Yeh; Tien, Hwei-Fang; Hou, Hsin-An; Chou, Wen-Chien; Lin, Liang-In

csf1 is required for early embryonic macrophage development: characterization of the csf1^op/csf1^op mutation in ES cell-derived macrophages
pp. 739-742(4)
Authors: Loureiro, Robyn M. B.; Monaco, Kelli-Ann; Kearney, Joseph B.; Blickarz-Durand, Courtney E.; Kirby, Suzanne L.; Inamdar, Maneesha S.; Bautch, Victoria L.

Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutations
pp. 742-743(2)
Authors: Zenz, T.; Döhner, K.; Denzel, T.; Döhner, H.; Stilgenbauer, S.; Bullinger, L.

Gemtuzumab ozogamicin plus cytarabine in elderly patients with relapsed or refractory acute myeloid leukaemia
pp. 744-745(2)
Authors: Doyen, Jérôme; Italiano, Antoine; Peyrade, Frédéric; Bouyer, Claude; Thyss, Antoine

Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis
pp. 745-747(3)
Authors: de Lavallade, Hugues; Punnialingam, Sinthiya; Milojkovic, Dragana; Bua, Marco; Khorashad, Jamshid S.; Gabriel, Ian H.; Chaidos, Aristeidis; Olavarria, Eduardo; Goldman, John M.; Apperley, Jane F.; Marin, David